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Abstract
Background: Acinetobacter baumannii is responsible for large epidemics in hospitals, where it can persist for long
time on abiotic surfaces. This study investigated some virulence-related traits of epidemic A. baumannii strains
assigned to distinct MLST genotypes, including those corresponding to the international clones I-III as well as
emerging genotypes responsible for recent epidemics.
Methods: Genotyping of bacteria was performed by PFGE analysis and MLST according to the Pasteur’s scheme.
Biofilm formation on polystyrene plates was assessed by crystal violet staining; resistance to desiccation was
evaluated on glass cover-slips when kept at room-temperature and 31% relative humidity; adherence to and
invasion of A549 human alveolar epithelial cells were determined by the analysis of viable bacteria associated with
or internalized by A549 human alveolar epithelial cells; Galleria mellonella killing assays were used to analyze the
virulence of A. baumannii in vivo.
Results: The ability to form biofilm was significantly higher for A. baumannnii strains assigned to ST2 (international
clone II), ST25 and ST78 compared to other STs. All A. baumannii strains survived on dry surfaces for over 16 days,
and strains assigned to ST1 (international clone I) and ST78 survived for up to 89 and 96 days, respectively.
Adherence to A549 pneumocytes was higher for strains assigned to ST2, ST25 and ST78 than other genotypes; a
positive correlation exists between adherence and biofilm formation. Strains assigned to ST78 also showed
significantly higher ability to invade A549 cells. No significant differences in the killing of G. mellonella worms were
found among strains.
Conclusions: Elevated resistance to desiccation, high biofilm-forming capacity on abiotic surfaces and adherence
to A549 cells might have favoured the spread and persistence in the hospital environment of A. baumannii strains
assigned to the international clones I and II and to the emerging genotypes ST25 and ST78.
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mellonella infection
* Correspondence: visca@uniroma3.it; rafzarri@unina.it
2Department of Biology, University “Roma Tre”, Rome, Italy
1Department of Public Health, University of Naples “Federico II”, Naples, Italy
© 2013 Giannouli et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Giannouli et al. BMC Infectious Diseases 2013, 13:282
http://www.biomedcentral.com/1471-2334/13/282
Background
Acinetobacter baumannii is an emerging bacterial patho-
gen responsible for widespread and persistent outbreaks
among hospitalized patients. A. baumannii infections
are difficult to control since many epidemic strains can
resist several classes of antibiotics and disinfectants and
are able to contaminate abiotic surfaces of the hospital
environment, including the medical equipment [1,2].
The vast majority of A. baumannii epidemics are caused
by a limited number of strains worldwide, belonging to
the initially named European clones, but now regarded
to as International clonal lineages (IC) I, II and III [3-5].
Additional A. baumannii genotypes have recently emer-
ged as epidemic clones in some regions, such as the
closely related ST15 and ST84 genotypes from Europe
[3,4], the ST25 genotype from Eurasia [4,6] and geno-
type ST78 isolated in several Italian hospitals [4,7]. Since
the majority of epidemic strains are multi-drug-resistant
(MDR) or extensively-drug-resistant (XDR) [8], many
studies have investigated the genetic and functional basis
of antimicrobial resistance [1,2,4-6]. In contrast, few
studies are available on the virulence traits and patho-
genic potential of A. baumannii. It has been reported
that A. baumannii can form biofilms on several abiotic
surfaces, including polystyrene, polypropylene, polytetra-
fluoroethylene and glass [9], and ca. 70% of strains
investigated in multicentre prospective cohort study
performed in 28 Spanish hospitals were biofilm-formers
[10]. While no difference in biofilm formation was ob-
served between outbreak and sporadic strains, IC-II
strains seem to form larger biofilms than IC-I strains
[11]. Biofilm formation appeared to be positively corre-
lated with multidrug resistance [10], as well as with the
expression of several virulence factors, including the
outer membrane protein OmpA, the extracellular poly-
saccharide poly-β-(1,6)-N-acetyl glucosamine (PNAG),
type I pili, a homologue of the staphylococcal biofilm-
associated protein (Bap), the outer membrane protein
CarO, a quorum sensing system and proteins involved in
histidine metabolism, such as urocanase [9,12-17]. The
ability of A. baumannii strains to survive for a long
time on dry surfaces is likely to contribute to their
persistence in hospitals [18]. In this respect, it has
been recently reported that RecA protein is involved
in general stress response and resistance to heat
shock and desiccation in A. baumannii [19]. In
addition, the ability of A. baumannii to adhere and
invade epithelial cells has been investigated [20].
Among the virulence factors that may contribute to
these processes, the Bap protein has been demon-
strated to play a role during adherence to epithelial
cells [21], and OmpA and phospholipase D have been
shown to contribute to invasion of epithelial cells
[15,22].
The majority of the above studies, however, have been
performed using a limited number of strains, often
ATCC 19606T and/or ATCC 17978 reference strains
[12,15,17,23]. Only a few studies have compared the
virulence traits of ICs I-III [11,23,24], while no studies
have analyzed the virulence features of other emerging
epidemic lineages. Although comparative genome ana-
lysis of twelve A. baumannii strains assigned to distinct
genotypes [25,26] and of 136 A. baumannii strains be-
longing to A. calcoaceticus-baumannii complex [27] has
demonstrated that the genes encoding putative virulence
factors are mostly conserved, phenotypic data on the ex-
pression of putative virulence factors disclosed variability
among strains, even those belonging to the same IC, likely
reflecting differences in expression levels [11,23,24].
The objective of the present study was to identify
virulence-related traits of epidemic strains assigned to
distinct genotypes of A. baumannii that could contribute
to their ability to colonize and infect the human host
and persist in the hospital environment. Biofilm forma-
tion, resistance to desiccation, adherence to and invasion
of A549 human bronchial cells, and killing of Galleria
mellonella caterpillars were evaluated for a diverse col-
lection of MDR or XDR A. baumannii strains isolated
during outbreaks in European hospitals, and in the refer-
ence strains ATCC 19606T and ATCC 17978.
Methods
Bacterial strains, cell line and culture conditions
Twenty-three A. baumannii strains isolated during out-
breaks that occurred in several Mediterranean hospitals
[4,28-31], plus A. baumannii ATCC19606T and ATCC
17978 reference strains [32,33] were included in the study
(Table 1). Epidemiological features of strains and number
of patients involved in the outbreaks were in accordance
to previous publications [4,28-31]. No ethical approval
was required for the study because there was no access
to patient data. Bacteria were routinely cultured in
Luria-Bertani broth (LB). Genotyping was performed by
pulsed-field gel electrophoresis (PFGE) and multilocus se-
quencing typing (MLST) analyses as previously described
[3,31]. Antimicrobial susceptibilities were determined by a
reference microdilution method [34]. MDR and XDR phe-
notypes were designed according to Magiorakos et al. [8].
The M9 minimal broth supplemented with magnesium
sulphate and glucose as carbon source (M9) and Mueller
Hinton broth (Oxoid, Milan, Italy) were used for biofilm
growth [35] and pellicle formation [36], respectively. A549
human alveolar epithelial cells were cultured as previously
described [15].
Measurement of biofilm formation
The ability of A. baumannii strains to form biofilm
was measured using a microtiter plate assay [37]. One
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hundred microliter aliquots of overnight cultures were
diluted to an optical density at 600 nm (OD600) of ~ 1.0.
and dispensed in 96-well polystyrene microtiter plates.
The number of bacterial cells in the supernatant was
monitored by OD600 measurements during 24 h growth
at 37°C. After removal of the culture, plates were washed
with phosphate-buffer saline solution (PBS) and air-
dried. Biofilm was stained with 0.1% crystal violet solu-
tion for 15 min. After washing with distilled water, the
biofilm-associated dye was solubilised with 200 μl of
95% ethanol and the OD540 was measured. The OD540/
OD600 ratio was used to normalize the amount of bio-
film formed to the total cell content. In order to assess
the induction of biofilm formation in the presence of
antibiotics, the bacteria were grown for 24 h in microti-
ter plates in the presence of imipenem (Merck Research
Laboratories, Rahway, N.J., USA) at sub-inhibitory con-
centrations as previously described [35]. Sub-inhibitory
concentrations of imipenem were 0.5 mg/L for strains
AYE, 700, 2979, LUH 5875, ATCC 19606T, and ATCC
17978, and of 4 mg/L for all other strains, which
corresponded to 1/4 and 1/4 – 1/16 the MIC, respect-
ively (Table 1). Three independent experiments, each
one performed in triplicate, were conducted for each
strain. For the pellicle formation at air-liquid interface
assay, bacteria were grown for 72 h at 37°C without
shaking, as previously described [36]. Positive air-liquid
biofilm samples were identify visually; the isolates were
considered positive when a pellicle was covering the
whole liquid surface.
Desiccation survival assay
The desiccation assay was performed as previously de-
scribed [18]. One ml aliquots of overnight LB cultures
were centrifuged at 11,600 × g for 5 min in a microcen-
trifuge. The cell pellet was washed twice with PBS and
suspended in distilled water to an OD600 of 1.0. Twenty
microliters of each suspension were deposited onto a
glass cover slip to produce an inoculum of ~2 × 107
colony-forming units (CFU). The coverslip was kept at
31% relative humidity by the presence of a saturated
CaCl2 × 6H2O in an uncovered Petri dish, and stored at
Table 1 Epidemiological, phenotypic and genotypic data of the A. baumannii isolates included in the study
Strain Isolate source Hospital Year Patientsa PFGE type MLST MDR/XDR IMP MIC
mg/L
Reference
AYE Urine Kremlin-Bicetre/FR 2001 12 A ST1 (IC-I) MDR 2 [28]
700 Blood culture F-Naples/IT 1999 81 B ST1 (IC-I) MDR 2 [4]
2979 Wound swab Agrigento/IT 2002 14 C ST20 (IC-I) MDR 2 [4]
3130 Blood culture SG-Beirut /LB 2004 17 D ST20 (IC-I) XDR 16 [4]
2105 Bronchial aspirate F-Naples /IT 2002 43 E ST2 (IC-II) XDR 16 [4]
3990 Central venous catheter M-Naples /IT 2006 12 E ST2 (IC-II) XDR 32 [31]
ACICU Cerebrospinal fluid Rome/IT 2005 14 E1 ST2 (IC-II) XDR 32 [30]
2735 Bronchial aspirate M-Naples /IT 2004 2 E2 ST2 (IC-II) XDR 64 [4]
3889 Bronchial aspirate Athens/GR 2005 4 F ST2 (IC-II) XDR 16 [4]
4026 Bronchial aspirate SJ-Beirut /LB 2007 5 G ST2 (IC-II) XDR 16 [4]
4009 Blood culture Genoa/IT 2007 4 H ST2 (IC-II) XDR 32 [4]
4025 Bronchial aspirate SG-Beirut /LB 2005 3 I ST3 (IC-III) XDR 16 [4]
LUH 5875 Blood culture Utrecht/NL, 1997 15 J ST3 (IC-III) MDR 2 [29]
3868 Bronchial aspirate Izmir/TK 2003 2 K ST15 XDR 16 [4]
3871 Bronchial aspirate Istanbul/TK 2003 1 K1 ST84 XDR 16 [4]
3890 Bronchial aspirate Thessaloniki/GR 2003 12 L ST25 XDR 16 [4]
3865 Blood culture Kocaeli/TK 2005 47 M ST25 XDR 64 [4]
4190 Blood culture M-Naples /IT 2009 3 N ST25 XDR 64 [4]
ATCC 19606T Urine Atlanta/USA Before 1949 1 O ST52 susceptible 2 [32]
ATCC 17978 Blood culture France 1951 1 P ST77 susceptible 2 [33]
3909 Bronchial aspirate M-Naples /IT 2007 55 Q ST78 XDR 16 [31]
3957 Bronchial aspirate M-Naples /IT 2007 55 Q ST78 XDR 16 [31]
3911 Blood culture M-Naples /IT 2007 1 Q1 ST78 XDR 16 [31]
Abbreviations: F-Naples, Federico II University Hospital, Naples; M-Naples, Monaldi Hospital, Naples; SG-Beirut, Saint Gorge Hospital, Beirut; SJ-Beirut, Saint Joseph
Hospital, Beirut; FR, France; GR, Greece; IT, Italy; LB, Lebanon; TK, Turkey; a Number of patients from whom an isolate with each particular PFGE type was detected;
MLST, Multi-locus sequencing typing; ST, sequence type; IC, international clone; IMP, imipenem; MIC, Minimum inhibitory concentration.
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room temperature in an air tight transparent plastic box
(17 × 11 × 5.5 cm) for up to 16 weeks. Strains were dis-
tributed into four separate boxes; each box stored up to
six strains. Viable cell counts were determined once a
week as previously described [23].
Adherence to and invasion of A549 cells
Adherence of A. baumannii strains to A549 cells
(human type 2 pneumocytes) was determined as de-
scribed previously [15], with minor modifications. In
brief, ~ 105 A549 cells were infected with ~ 107 bacterial
CFU and incubated for 60 min at 37°C in 5% CO2 (v/v)
atmosphere. Non-adherent bacterial cells were removed
by washing with PBS. Infected cells were lysed by the
addition of 1 ml distilled water and serial 10-fold dilu-
tions were plated on LB agar to determine the number
of CFU of adherent bacteria. To determine adherent and
invading bacteria, A549 cells were infected with A.
baumannii strains as described above. The monolayers
were then treated with 1 ml of fresh culture medium
containing 5 mg/L of colistin sulfate (Sigma-Aldrich,
Milan, Italy) for further 30 min, the shortest time point
that resulted in the killing of all extracellular bacteria
added to the monolayers. All strains included in the
study were killed after a 30 min treatment with 5 mg/L
of colistin. Afterwards, the cells were washed with PBS,
harvested with trypsin, and lysed with sterile distilled
water. Dilutions from harvested samples were inoculated
on LB agar plates and bacterial colony counts were esti-
mated after overnight incubation at 37°C. Each experi-
ment was performed in triplicate.
G. mellonella killing assay
The virulence of A. baumannii in vivo was assessed
using the G. mellonella insect model of infection [23],
with minor modifications. Ten G. mellonella caterpillars
(average weight 500 ± 60 mg) were injected with 10 μl of
serial ten-fold dilutions in PBS of A. baumannii cells
grown overnight at 37°C in LB. Bacterial colony counts
(CFU/ml) on LB agar plates were used to estimate the
number of viable cells in each inoculum. Ten larvae that
received no injection and ten larvae injected with 10 μl
PBS were used as negative controls of each experiment.
Two independent experiments, each one performed in
triplicate (thirty larvae for each strain), were conducted
for each strain. Larvae were incubated at 37°C in Petri
dishes (ten larvae per dish) and monitored every 12 h
for a total of 72 h. Survival curves were plotted using
the Kaplan-Meier estimator and expressed in percentage.
Lethal dose 50% (LD50) values were calculated using
GraphPad Prism v.5.04 (GraphPad Software, La Jolla
California USA) according to the following equation:
Y= A + (1-A)/(1 + e(B–G×lnX)), where X is the number of
viable bacterial cells injected, Y the fraction of larvae
killed by a given bacterial inoculum, A is the fraction of
larvae killed by the control solution, and B and G
are curve-fitting constants automatically calculated by
GraphPad Prism [23]. LD50 values were calculated as the
value of X that corresponds to Y = 0.5.
Statistical analysis
Data were analysed using Statistical Package for the
Social Sciences Version 13.0 (SPSS Inc., Chicago, IL,
USA). The significance of the induction of biofilm for-
mation in the presence of imipenem was analyzed with
the Student’s t test and induction was considered signifi-
cant when the P value was <0.05. The variability of
strains assigned to the same ST was investigated using
the One-Way Analysis of Variance (ANOVA), in which
strains were grouped according to ST and differences
were considered significant when the P value was <0.05.
Correlations were evaluated by regression analysis using
the Pearson’s correlation coefficient (r).
Results
Biofilm formation
Twenty-three A. baumannii strains isolated during out-
breaks that occurred in several hospitals in France,
Greece, Italy, Lebanon, Netherlands and Turkey
[4,28-31], and A. baumannii ATCC19606T and ATCC1
7978 reference strains [32,33] were investigated. The
strains had previously been assigned to 10 different
MLST sequence types (STs) and to 17 different major
PFGE types. The collection includes strains assigned to
major international clones IC-I, IC-II and IC-III and
additional emerging genotypes ST15, ST25 and ST78.
The majority of the strains were representative of cross-
transmission episodes and were isolated with identical
PFGE type from more than two patients of the same or
different institutions. Strains 3909 and 3957 assigned to
ST78 were isolated with identical PFGE type Q from dif-
ferent patients during the same inter-hospital outbreak
[31]. Seventeen strains exhibited an imipenem minimum
inhibitory concentration (MIC) ≥16 mg/L and were
considered to be carbapenem-resistant and XDR; four
strains were classified as MDR (Table 1).
The ability to form biofilm on polystyrene microtiter
plates was evaluated for outbreak A. baumannii strains
assigned to different PFGE genotypes and STs (Table 1).
Strains assigned to the four major PFGE types E-H (ST2,
corresponding to IC-II), PFGE types L-N (ST25), and
PFGE type Q (ST78) formed significantly higher biofilm
levels than strains assigned to other PFGE types (inclu-
ding ST1, ST20, ST3, ST15, ST84, ST52, and ST77)
(p <0.05) (Figure 1A). No relevant differences in growth
yelds were observed among the strains, thus excluding
the possibility that difference in biofilm formation were
due to difference in bacterial growth. In addition, A.
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baumannii strains assigned to ST2, ST25 and ST78
formed a robust biofilm pellicle at the air-liquid interface
when grown at 37°C for 72 h without shaking (data not
shown).
Since exposure of A. baumannii to sub-inhibitory con-
centrations of imipenem has been demonstrated to
stimulate biofilm growth [35], a biofilm formation assay
was performed in the presence of sub-inhibitory concen-
trations of the antibiotic (Figure 1B). Growth yields were
not affected by imipenem at the used concentrations for
all strains tested. Compared with the untreated control,
significantly higher biofilm levels were observed after ex-
posure to imipenem for strains assigned to ST2 (except
strain 3889), and ST78, which already produced high
biofilm levels before treatment, and for strains assigned
to ST1 and its single locus variant ST20 (IC-I), to ST3
(IC-III) and to ST52 (ATCC 19606T) (p <0.05) which,
conversely, were weak producers when grown in the
absence of antibiotic. On the other hand, no significant
differences in biofilm formation were observed for
the strains assigned to ST15, ST84 ST25 and ST77

























































































































































































Figure 1 Biofilm formation. Biofilm formation on 96-well polystyrene microtiter plates by A. baumannii grown statically in M9 medium for 24
hours in the absence (panel A) or presence (panel B) of imipenem concentrations 0.5 mg/L (strains AYE, 700, LUH 5875, 2979, ATCC 19606T and
ATCC 17978), or 4 mg/L (all other strains). Strain and ST types are indicated on the bottom of the figure. Error bars represent standard deviations
based on three independent experiments. Asterisks indicate statistically significant differences in biofilm formation among different STs (panel A)
(p <0.05) and statistically significant induction in biofilm formation upon exposure to sub-MIC imipenem concentrations (panel B) (p <0.05).
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Resistance to desiccation
Strains showed an overall ability to resist desiccation,
though survival times ranged from 16 to 96 days
depending on the strain (Figure 2 and Additional file 1:
Table S1). In particular, strains assigned to ST1 and
ST78 showed extremely high resistance to desiccation,
with survival times of 75 to 89 days and 68 to 96 days,
respectively. Strains assigned to ST15, strain 4025 (ST3)
and strain 3890 (ST25) showed a comparable trend of
high resistance to desiccation, with survival times of 75
to 89 days. Strains assigned to ST2 and ST20, strains
4190 and 3865 (assigned to ST25) and strain ATCC
17978 were moderately resistant to desiccation with sur-
vival times of 33 to 54 days. Finally, strains 3871
(assigned to ST84), LUH 5875 (assigned to ST3) and
ATCC 19606T were less resistant to dry conditions, and
survived for < 29 days (Figure 2 and Additional file 1:
Table S1).
Adherence to and invasion of A549 human bronchial cells
Different steps of the interaction between A. baumannii
and A549 human alveolar epithelial cells were investi-
gated, including adherence to epithelial cells and subse-
quent invasion [15]. A. baumannii strains displayed
different ability to adhere to epithelial cells (Figure 3A).
In particular, all strains assigned to ST2, ST25, ST78 and
strain ATCC 17978 adhered to epithelial cells at
significantly higher levels than other strains (p <0.05).
Moreover, a highly significant correlation was found
between adhesiveness of A. baumannii to A549 human
alveolar epithelial cells and biofilm formation for
all strains, except ATCC 19606T and ATCC 17978
(r = 0.832, p <0.01).
Strains assigned to ST1, ST20, ST2, ST25 and ST78
and reference strain ATCC 19606T were all invasive, al-
though only strains assigned to ST78 showed signifi-
cantly high levels of invasiveness when compared with
other genotypes (p <0.05) (Figure 3B). A similar number
of bacteria adhered to A549 cells when the monolayers
were incubated with A. baumannii strains for 60 min at
4°C, i.e. under conditions that do not allow for tissue in-
vasion (data not shown).
G. mellonella killing assays
The LD50 values were calculated for each strain at 24, 48
and 72 h post-infection (Table 2). For all strains, the
LD50 decreased with post-infection time, attaining the
final value at 72 h (Additional file 2: Figure S1). No rele-
vant difference in larval death was observed at the sub-
sequent time points (data not shown). Differences in
LD50 between 24 h and 72 h provide a trend of the kill-
ing rapidity for individual strains (Table 2 and Additional
file 2: Figure S1). The LD50 at 72 h were comprised




















































Figure 2 Resistance to desiccation. Resistance to desiccation of A. baumannii strains. Strains were inoculated onto rounded glass cover slips
and incubated at 31% relative humidity and room temperature. A starting bacterial inoculum of ~ 2 × 107 per cover slip was used. Values
represent the mean of three independent experiments.
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average LD50 being 5.8(±9.5) × 10
5 CFU/larva. These
values are in the range of those determined in a pre-
vious study on clinical A. baumannii isolates [23].
Strain-specific differences between LD50 calculated at
72 h were significant (p <0.001). In particular, strains
ATCC 19606T (ST52) and 3868 (ST15) had signifi-
cantly (p <0.001) higher LD50 than all the other
strains tested. In contrast, ST-specific differences be-
tween LD50 calculated at 72 h were not significant
(p ≥0.05).
Discussion
Antibiotic resistance and long-term persistence in the
hospital environment are two factors that most likely
contribute to the success of A. baumannii as an oppor-
tunistic pathogen [1,2,5]. However, it is possible that the
emergence of some epidemic strains or clones over
others is the result of an improved ability to colonize pa-
tients and cause disease. In attempt to address this issue,
biofilm formation, resistance to desiccation, adherence
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Figure 3 Bacterial adherence to and invasion of A549 bronchial epithelial cells. (A) Cell surface-associated bacteria after 60 min incubation
at 37°C. Statistically significant differences (p <0.05) among different STs are indicated with asterisks. (B) Intracellular bacterial counts (CFU/well)
obtained after 60 min incubation of A549 cells with bacterial strains and subsequent treatment for 30 min at 37°C with colistin (5 mg/L).
Statistically significant differences among different STs (p <0.05) are indicated with asterisks. Each value represents the mean ± standard deviation
(error bar) of three independent experiments performed in duplicate.
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of A. baumannii to kill G. mellonella catterpilars were
investigated as possible virulence-related phenotypes
among A. baumannii isolates belonging to the main ICs
and to recently emerging clones [10,15,18,23]. To this
purpose, a collection of 21 A. baumannii strains
assigned to the three main lineages circulating world-
wide, i.e. IC-I, II and III, as well as to distinct genotypes
recently identified as responsible for outbreaks, and two
reference A. baumannii strains ATCC 19606T and ATCC
17978 were selected (Table 1).
Results demonstrate that epidemic A. baumannii ge-
notypes differ in the ability to form biofilm on abiotic
surfaces. In particular, strains assigned to genotypes ST2,
ST25 and ST78 produce biofilm more efficiently and are
able to form a robust biofilm pellicle at the air-liquid
interface of the culture medium. In keeping with this re-
sult, it has been shown that strains belonging to the A.
baumannii-calcoaceticus complex form higher biofilm
pellicle than other Acinetobacter species [36] and that A.
baumannii strains assigned to the IC-II form more bio-
film than A. baumannii strains assigned to the IC-I [11].
It is also worth mentioning that the A. baumannii strain
SMAL, responsible for two outbreaks in Northern Italy
and shown to be an efficient biofilm producer [35], has
recently been assigned to ST78 [7]. Biofilm could there-
fore be regarded as an important virulence feature for A.
baumannii strains belonging to ST2, ST78 and also
ST25. In consistence with previous findings [35], our
study also demonstrates that exposure to sub-inhibitory
concentrations of imipenem has an overall stimulating
effect on biofilm formation as shown for epidemic
strains assigned to ST1, ST2, ST3, ST20 and ST78. It is
plausible that transition from planktonic to biofilm life-
style upon imipenem exposure represents a defensive
response of A. baumannii to the threat posed by the
antibiotic challenge.
Most of the A. baumannii outbreak strains analyzed
herein showed an impressive ability to survive on dry
surfaces for long times, consistent with the overall cap-
acity of this species to resist to drought [18,23,38].
Strain-dependent variation was found also for this char-
acter, since strains assigned to ST1 and ST78, as well as
one strain assigned to ST25, showed extremely high re-
sistance to desiccation; strains assigned to ST20, which





24/72 h24 h 48 h 72 h
AYE ST1 2.8 (±0.3) × 106 5.4 (±0.3) × 105 2.3 (±0.1) × 105 12.2
700 ST1 7.2 (±4.2) × 105 2.7 (±0.5) × 105 2.3 (±0.4) × 105 3.1
2979 ST20 1.0 (±0.2) × 106 6.6 (±0.2) × 105 4.2 (±0.6) × 105 2.4
3130 ST20 7.3 (±0.3) × 105 5.8 (±0.6) × 105 5.8 (±0.6) × 105 1.3
2105 ST2 9.2 (±0.6) × 105 8.2 (±0.5) × 105 7.4 (±0.7) × 105 1.2
3990 ST2 6.6 (±0.7) × 105 1.1 (±0.2) × 105 8.1 (±0.5) × 104 8.1
ACICU ST2 1.3 (±0.4) × 106 7.4 (±0.3) × 105 6.4 (±0.9) × 105 2.0
2735 ST2 2.2 (±0.3) × 105 2.0 (±0.1) × 105 1.3 (±0.7) × 105 1.7
3889 ST2 4.2 (±0.4) × 105 2.4 (±0.1) × 105 1.8 (±0.2) × 105 2.3
4026 ST2 4.5 (±0.6) × 105 2.7 (±0.5) × 105 2.7 (±0.5) × 105 1.7
4009 ST2 3.7 (±0.2) × 105 3.2 (±0.7) × 105 3.0 (±0.7) × 105 1.2
4025 ST3 9.4 (±0.2) × 105 2.7 (±0.9) × 105 2.2 (±0.8) × 105 4.3
LUH 5875 ST3 3.8 (±1.2) × 105 2.8 (±0.2) × 105 2.3 (±0.1) × 105 1.7
3868 ST15 2.3 (±0.5) × 106 2.3 (±0.6) × 106 1.6 (±0.1) × 106 1.4
3871 ST84 5.8 (±0.3) × 105 3.9 (±0.5) × 105 3.5 (±0.3) × 105 1.7
3890 ST25 6.6 (±0.8) × 105 4.6 (±0.3) × 105 2.4 (±0.4) × 105 2.8
3865 ST25 1.6 (±0.4) × 106 1.3 (±0.1) × 106 3.0 (±0.3) × 105 5.3
4190 ST25 3.1 (±0.5) × 106 2.1 (±0.3) × 106 5.0 (±0.9) × 105 6.0
ATCC 19606T ST52 9.1 (±3.4) × 106 6.7 (±0.7) × 106 4.7 (±0.2) × 106 1.9
ATCC 17978 ST77 6.7 (±0.1) × 105 4.5 (±0.7) × 105 3.1 (±0.6) × 105 2.2
3909 ST78 2.0 (±0.4) × 106 6.4 (±0.7) × 105 6.4 (±0.7) × 105 3.1
3957 ST78 3.3 (±1.2) × 105 2.8 (±0.4) × 105 2.5 (±0.6) × 105 1.3
3911 ST78 7.8 (±1.9) × 105 5.6 (±0.6) × 105 1.4 (±0.6) × 105 5.6
aLD50 values are expressed as CFU/larva.
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belong to the same clonal complex as ST1, all ST2
strains, and two of three strains assigned to ST25 were
moderately resistant to desiccation; in contrast, six other
strains, including ATCC 19606T, were less resistant to
drought. It has recently been reported that the survival
times on dry surfaces of A. baumannii biofilm-forming
strains are longer than those of non-biofilm-forming
ones [38]. However, the collection analysed in this study
did not reveal a strong correlation between biofilm for-
mation and survival to desiccation, except for strains
assigned to ST78 and two out of three strains assigned
to ST25. A possible explanation for this discrepancy is
that this correlation depends on the strains and/or cul-
ture conditions used.
The data obtained in this study also indicate that A.
baumannii clonal lineages differ in the ability to adhere
to alveolar epithelial cells. In particular, adherence to
A549 cells was higher for strains assigned to ST2, ST25
and ST78, and a positive correlation exists between ad-
herence to epithelial cells and biofilm formation in these
strains. This is consistent with a previous report showing
a positive association between biofilm production and
adhesiveness to epithelial cells in MDR clinical isolates
of A. baumannii [20]. Therefore, it can be speculated
that common or partly overlapping cellular mechanisms
might control biofilm growth on abiotic surfaces and
adherence to epithelial cells. In partial support of this
hypothesis, it was recently shown that the biofilm-
associated protein Bap plays a role in both biofilm
formation and adherence to human epithelial cells [21].
Our study also demonstrated that A. baumannii strains
assigned to ST78 have a higher ability to invade A549
human bronchial epithelial cells than other genotypes.
However, since the three strains assigned to ST78 belong
to the same major PFGE type, it cannot be excluded that
differences in the capacity to invade epithelial cells are
strain-specific rather than lineage-specific.
No significant differences in the killing of G. mello-
nella larvae, measured as the LD50 at the 72 h post-
infection time point, were found among strains
assigned to the distinct genotypes, with the exception
of strains ATCC 19606T (ST52) and 3868 (ST15),
which showed significantly lower virulence. However,
strain-specific differences were observed in the rate of
killing, expressed as the ratio between LD50 values
determined at 24 and 72 h. Killing was delayed for
strains AYE (ST1) and 3990 (ST2) and, to a lesser
extent, 3865, 4190 (both ST25) and 3911 (ST78)
(LD50 ratio 5.3-12.2; Table 2 and Additional file 2:
Figure S1). Overall, the LD50 values determined for
our collection of isolates is in the same order of mag-
nitude as that previously reported for prototypic A.
baumannii strains of clinical origin (AYE, ACICU
and ATCC 17978) [23].
The data just discussed indicate that, in spite of some
interclonal variation, biofilm formation, adherence to
epithelial cells and resistance to desiccation are virulence
traits shared by A. baumannii clinical strains, irrespect-
ive of their belonging to the major or minor lineages.
This is consistent with previous work [10,18,23,38], in-
cluding some recent publications showing that several
genes associated with A. baumannii pathogenicity are
more conserved in the A. calcoaceticus-baumannii (Acb)
complex, and especially in A. baumannii, than in other
Acinetobacter genomes, and that the most successful A.
baumannii strains, although epidemiologically and geno-
typically different, share a common set of virulence-
related traits in their core genome [25-27].
Conclusions
In conclusion, although epidemic A. baumannii clonal
lineages show common virulence traits, they differ in the
expression of virulence-associated phenotypes. In par-
ticular, A. baumannii strains belonging to IC-I showed
higher resistance to desiccation, strains belonging to IC-
II showed higher adherence to both biotic and abiotic
surfaces, strains belonging to emerging genotypes ST25
and ST78 showed elevated resistance to desiccation,
adherence to biotic and abiotic surfaces. Also, to the best
of our knowledge, this is the first study to identify
common A. baumannii virulence-associated phenotypes
(resistance to desiccation, adherence to biotic and abi-
otic surfaces and alveolar epithelial cell invasion) in epi-
demic genotypes other than the three main ICs. Non-IC
genotypes have increasingly been reported as responsible
of hospital epidemics [5], and our findings are a first
step towards the elucidation of virulence strategies that
might have favoured the spread and persistence in the
hospital environment of these emerging sequence types.
Additional files
Additional file 1: Table S1. Resistance to desiccation of A. baumannii
strains. Values are means ± standard deviations of three independent
experiments done in duplicate.
Additional file 2: Figure S1. Kaplan-Meier survival plots of G. mellonella
larvae infected with the different A. baumannii strains.
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